基于6年随访:上皮样肉芽肿与克罗恩病严重程度增加及进展相关
该回顾性研究纳入1466例克罗恩病患者,187例(12.8%)检出肉芽肿。肉芽肿与C反应蛋白升高(OR 2.9)、诊断年龄更小、狭窄或穿透型表型比例更高、激素及麻醉药品使用率更高相关;手术患者中肉芽肿与6年内再次手术相关(OR 2.5)。
要点
- 1466例克罗恩病患者中187例(12.8%)检出上皮样肉芽肿。
- 肉芽肿与C反应蛋白升高相关(OR 2.9,95%CI 2.078-4.208,P<.0001)。
- 手术患者中肉芽肿与6年内再次手术相关(OR 2.5,95%CI 1.54-4.02,P=.0002)。
核心结论
- 上皮样肉芽肿见于不足13%的克罗恩病患者,并与更侵袭性的疾病表型相关。
- 因克罗恩病接受手术且存在肉芽肿的患者,6年内再次手术风险增加。
研究设计与样本
- 回顾性研究,纳入美国匹兹堡大学炎症性肠病中心2009年至2014年诊治的克罗恩病患者,按有无组织学肉芽肿证据分组。
- 共纳入1466例克罗恩病患者,其中187例(12.8%)检出肉芽肿;在接受手术的患者亚组中,21.0%有肉芽肿。
- 采用Mann-Whitney U检验比较连续变量,并进行关联分析和生存分析。
主要发现
- 肉芽肿与血清C反应蛋白水平升高相关(OR 2.9,95%CI 2.078-4.208,P<.0001)。
- 肉芽肿组诊断时平均年龄23.6±11.3岁,无肉芽肿组27.9±13.3岁(P=.0005)。
- 肉芽肿与狭窄或穿透型疾病表型比例更高、激素和麻醉药品使用率更高及医疗资源利用更多相关。
- 在接受手术的患者中,肉芽肿与6年观察期内需再次手术相关(OR 2.5,95%CI 1.54-4.02,P=.0002)。
- 与未接受生物制剂治疗的患者相比,英夫利西单抗使用与手术标本中肉芽肿检出比例显著更低相关(OR 0.22,95%CI 0.05-0.97,P=.03)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Epithelioid granulomas are characteristics of a subset of patients with Crohn's disease (CD), but their significance, with regard to disease progression and severity, is unclear. We investigated the relationship between granulomas and CD severity over a 6-year time period in a large cohort of patients. METHODS: We performed a retrospective study of patients with CD seen at the Inflammatory Bowel Disease Center at the University of Pittsburgh; data were collected from 2009 through 2014 and patients were assigned to groups with and without histologic evidence of granuloma. Demographic, clinical (including disease activity, quality of life, medication use, and healthcare utilization), and laboratory data were used in association and survival analyses. Differences between groups were evaluated using the Mann-Whitney U-test for continuous variables. RESULTS: Of 1466 patients with CD, granulomas were identified in 187 (12.8%). In the subset of patients who underwent surgery, 21.0% had granulomas. The presence of granuloma was associated with increased serum levels of c-reactive protein (odds ratio [OR], 2.9; 95% CI, 2.078-4.208; P < .0001), younger mean age at diagnosis (23.6 ± 11.3 years in patients with granulomas vs 27.9 ± 13.3 years in patients without; P = .0005), higher rates of stricturing or penetrating disease phenotype, higher rates of steroid and narcotic use, and higher healthcare utilization. Among patients that underwent surgery, the presence of granulomas was associated with need for repeat surgery during the 6-year observation period (OR, 2.5; 95% CI, 1.54-4.02; P = .0002). Infliximab use was associated with detection of granuloma in a significantly lower proportion of surgical specimens compared to patients who had not been treated with a biologic agent (OR, 0.22; 95 CI, 0.05-0.97; P = .03). CONCLUSIONS: Epithelioid granulomas develop in less than 13% of patients with CD, and are associated with a more aggressive disease phenotype. Patients who have undergone surgery for CD and have granulomas are at increased risk for repeat surgery within 6 years.
引用
- Johnson CM, Hartman DJ, Ramos-Rivers C, et al. Epithelioid Granulomas Associate With Increased Severity and Progression of Crohn's Disease, Based on 6-Year Follow-Up. Clin Gastroenterol Hepatol. 2017. PMID: 29277619. doi:10.1016/j.cgh.2017.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。